Assignee
BOSTONGENE CORP
US·36 granted patents·26 pending applications·164 citations·filing 2018–2025
Top patents by PatentIndex Score
62 records- 0197US11302420B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2020·Granted Apr 12, 2022·8 cites·30 claims
- 0297US10580517B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2019·Granted Mar 3, 2020·11 cites·30 claims
- 0397US10311967B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted Jun 4, 2019·25 cites·25 claims
- 0496US10340030B2Systems and methods for identifying cancer treatments from normalized biomarker scoresBOSTONGENE CORP·Filed 2018·Granted Jul 2, 2019·13 cites·22 claims
- 0596US10340031B2Systems and methods for identifying cancer treatments from normalized biomarker scoresBOSTONGENE CORP·Filed 2018·Granted Jul 2, 2019·13 cites·24 claims
- 0695US11705220B2Systems and methods for identifying cancer treatments from normalized biomarker scoresBOSTONGENE CORP·Filed 2021·Granted Jul 18, 2023·2 cites·16 claims
- 0795US11373733B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2020·Granted Jun 28, 2022·3 cites·20 claims
- 0895US10650911B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted May 12, 2020·8 cites·11 claims
- 0995US10504615B2Using cancer or pre-cancer subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and generate a graphical user interfaceBOSTONGENE CORP·Filed 2019·Granted Dec 10, 2019·9 cites·30 claims
- 1095US10395761B1Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2019·Granted Aug 27, 2019·9 cites·30 claims
- 1193USD891446SDisplay screen or portion thereof with graphical user interfaceBOSTONGENE CORP·Filed 2019·Granted Jul 28, 2020·4 cites·1 claims
- 1292US11367509B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted Jun 21, 2022·4 cites·21 claims
- 1392US11004542B2Using subject sequencing data and a database of therapy biomarker distributions to determine therapy impactBOSTONGENE CORP·Filed 2020·Granted May 11, 2021·2 cites·16 claims
- 1492USD890779SDisplay screen or portion thereof with graphical user interfaceBOSTONGENE CORP·Filed 2019·Granted Jul 21, 2020·3 cites·1 claims
- 1591US10720230B2Method for administering a checkpoint blockade therapy to a subjectBOSTONGENE CORP·Filed 2018·Granted Jul 21, 2020·4 cites·9 claims
- 1691US10706954B2Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapyBOSTONGENE CORP·Filed 2019·Granted Jul 7, 2020·3 cites·16 claims
- 1790US11430545B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted Aug 30, 2022·2 cites·23 claims
- 1890US11322226B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted May 3, 2022·2 cites·16 claims
- 1990US10636513B2Using cancer or pre-cancer subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and generate a graphical user interfaceBOSTONGENE CORP·Filed 2019·Granted Apr 28, 2020·3 cites·30 claims
- 2090US10636514B2Using subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and therapy scoresBOSTONGENE CORP·Filed 2019·Granted Apr 28, 2020·3 cites·30 claims
- 2190US2024290434A1Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2024·Application pending·0 cites
- 2289US11587642B2Systems and methods for deconvolution of expression dataBOSTONGENE CORP·Filed 2022·Granted Feb 21, 2023·2 cites·20 claims
- 2389US2024006029A1Systems and methods for predicting therapy efficacy from normalized biomarker scoresBOSTONGENE CORP·Filed 2023·Application pending·0 cites
- 2487US11315658B2Systems and methods for deconvolution of expression dataBOSTONGENE CORP·Filed 2021·Granted Apr 26, 2022·5 cites·15 claims
- 2587US11250568B2Techniques for determining tissue characteristics using multiplexed immunofluorescence imagingBOSTONGENE CORP·Filed 2021·Granted Feb 15, 2022·3 cites·31 claims
- 2683US2022389512A1Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 2782US11984200B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted May 14, 2024·1 cites·20 claims
- 2877US11482301B2Gene expression analysis techniques using gene rankings and statistical models for identifying biological sample characteristicsBOSTONGENE CORP·Filed 2020·Granted Oct 25, 2022·1 cites·33 claims
- 2975US11842797B2Systems and methods for predicting therapy efficacy from normalized biomarker scoresBOSTONGENE CORP·Filed 2019·Granted Dec 12, 2023·0 cites·20 claims
- 3074US12205675B2Techniques for bias correction in sequence dataBOSTONGENE CORP·Filed 2020·Granted Jan 21, 2025·1 cites·1 claims
- 3174US11568959B2Tumor microenvironment-based methods for assessing CAR-T and other immunotherapiesBOSTONGENE CORP·Filed 2021·Granted Jan 31, 2023·1 cites·4 claims
- 3274US2023178178A1Systems and methods for deconvolution of expression dataBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 3373USD892825SDisplay screen or portion thereof with graphical user interfaceBOSTONGENE CORP·Filed 2019·Granted Aug 11, 2020·13 cites·1 claims
- 3471US2025125013A1Hierarchical machine learning techniques for identifying molecular categories from expression dataBOSTONGENE CORP·Filed 2024·Application pending·0 cites
- 3569US2024161284A1Techniques for determining tissue characteristics using multiplexed immunofluorescence imagingBOSTONGENE CORP·Filed 2024·Application pending·0 cites
- 3669US2026038698A1Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltrationBOSTONGENE CORP·Filed 2025·Application pending·0 cites
- 3768US2022375543A1Techniques for single sample expression projection to an expression cohort sequenced with another protocolBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 3868US2024379188A1Techniques for single sample expression projection to an expression cohort sequenced with another protocolBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 3967US2024029884A1Techniques for detecting homologous recombination deficiency (hrd)BOSTONGENE CORP·Filed 2023·Application pending·0 cites
- 4066US12462941B2Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltrationBOSTONGENE CORP·Filed 2024·Granted Nov 4, 2025·0 cites·19 claims
- 4166US2023073731A1Gene expression analysis techniques using gene ranking and statistical models for identifying biological sample characteristicsBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 4264US2025029677A1Techniques for identifying her2-low breast cancer tumorsBOSTONGENE CORP·Filed 2024·Application pending·0 cites
- 4363US11915422B2Techniques for determining tissue characteristics using multiplexed immunofluorescence imagingBOSTONGENE CORP·Filed 2021·Granted Feb 27, 2024·0 cites·31 claims
- 4463US2022119881A1Systems and methods for sample preparation, sample sequencing, and sequencing data bias correction and quality controlBOSTONGENE CORP·Filed 2021·Application pending·0 cites
- 4563US2022307088A1B cell-enriched tumor microenvironmentsBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 4663US2022223227A1Machine learning techniques for identifying malignant b- and t-cell populationsBOSTONGENE CORP·Filed 2021·Application pending·0 cites
- 4760US12580049B2Tumor microenvironment-based methods for assessing CAR-T and other immunotherapiesBOSTONGENE CORP·Filed 2022·Granted Mar 17, 2026·0 cites·5 claims
- 4860US11904002B2Construction and methods of use of a therapeutic cancer vaccine library comprising fusion-specific vaccinesBOSTONGENE CORP·Filed 2019·Granted Feb 20, 2024·0 cites·6 claims
- 4960US2022290254A1B cell-enriched tumor microenvironmentsBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 5060US2022186318A1Techniques for identifying follicular lymphoma typesBOSTONGENE CORP·Filed 2021·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when BOSTONGENE CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →